Longview Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
VCM
VPM
Longview Partners's CME Position: Q1 2026 in Review
Longview Partners reduced its CME Group (CME) stake by 27% in Q1 2026, selling an estimated $110M and leaving 1,016,950 shares worth $300M. The position accounts for 4.26% of the portfolio, ranked #14.
Longview Partners first reported a position in CME in Q4 2025 and has held it in 2 quarters since. The position peaked at $379M in Q4 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Longview Partners held 1,016,950 shares of CME Group worth $300M as of Q1 2026.
- Longview Partners sold 369,818 CME Group shares in Q1 2026, an estimated $110M.
- CME Group made up 4.26% of Longview Partners's portfolio in Q1 2026, its #14 holding.
- Longview Partners first reported a position in CME Group in Q4 2025 and has held it in 2 quarters since.
- Longview Partners's CME Group position peaked at $379M in Q4 2025.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Longview Partners's 13F filing for Q1 2026, filed 15 May 2026.